186 related articles for article (PubMed ID: 12739339)
1. [Standards, Options and Recommendations for the use of PET-FDG in cancerology. Results in urological cancers].
Bourguet P;
Bull Cancer; 2003 Feb; 90 Spec No():S80-7. PubMed ID: 12739339
[No Abstract] [Full Text] [Related]
2. [Standards, Options and Recommendations for the use of PET-FDG in cancerology. Results in sarcomas].
Bourguet P;
Bull Cancer; 2003 Feb; 90 Spec No():S96-102. PubMed ID: 12739341
[No Abstract] [Full Text] [Related]
3. Possible role of FDG-PET in the evaluation of urologic malignancies.
Bender H; Schomburg A; Albers P; Ruhlmann J; Biersack HJ
Anticancer Res; 1997; 17(3B):1655-60. PubMed ID: 9179213
[TBL] [Abstract][Full Text] [Related]
4. FDG in Urologic Malignancies.
Høilund-Carlsen PF; Poulsen MH; Petersen H; Hess S; Lund L
PET Clin; 2014 Oct; 9(4):457-68, vi. PubMed ID: 26050947
[TBL] [Abstract][Full Text] [Related]
5. [2006 technology monitoring report: clinical practice guideline: use of FDG-PET in kidney, prostate, testis and bladder cancers].
Bourguet P; Planchamp F; Montravers F; Vincendeau S; ;
Prog Urol; 2007 Apr; 17(2):172-5. PubMed ID: 17489312
[No Abstract] [Full Text] [Related]
6. Diagnosis and monitoring of urological tumors using positron emission tomography.
Hofer C; Kübler H; Hartung R; Breul J; Avril N
Eur Urol; 2001 Nov; 40(5):481-7. PubMed ID: 11752853
[TBL] [Abstract][Full Text] [Related]
7. [Recommendation for clinical practice: use of PET-FDG in cancer of the kidney, prostate, testicles, and the urinary bladder].
Bourguet P; Planchamp F; Montravers F; Vincendeau S; Courbon F; Edeline V; Helal BO; Rossi D; Villers A; ; ; ; ; ; ; ;
Bull Cancer; 2006 Dec; 93(12):1228-32. PubMed ID: 17191352
[No Abstract] [Full Text] [Related]
8. Recent developments in urologic oncology: positron emission tomography molecular imaging.
Bouchelouche K; Oehr P
Curr Opin Oncol; 2008 May; 20(3):321-6. PubMed ID: 18391633
[TBL] [Abstract][Full Text] [Related]
9. [Accuracy of computed tomography in urological tumour diagnosis (author's transl)].
Latal D; Kuber W; Imhof H; Küster W
Wien Klin Wochenschr; 1981 Jun; 93(13):415-20. PubMed ID: 7269622
[TBL] [Abstract][Full Text] [Related]
10. Lymphography as a diagnostic aid in urology.
Brillenburg Wurth GH; Bakker NJ; Tjabbes D
Arch Chir Neerl; 1967; 19(3):233-50. PubMed ID: 5212324
[No Abstract] [Full Text] [Related]
11. [Standards, Options and Recommendations for the use of PET-FDG in cancerology. Results in cancer of the upper aerodigestive tract].
Bourguet P;
Bull Cancer; 2003 Feb; 90 Spec No():S67-79. PubMed ID: 12739338
[No Abstract] [Full Text] [Related]
12. Fluorodeoxyglucose positron emission tomography in the evaluation of germ cell tumours at relapse.
Hain SF; O'Doherty MJ; Timothy AR; Leslie MD; Harper PG; Huddart RA
Br J Cancer; 2000 Oct; 83(7):863-9. PubMed ID: 10970686
[TBL] [Abstract][Full Text] [Related]
13. Usefulness of PET/CT 18-FDG for the diagnosis and follow-up of urological, urothelial and kidney tumours.
González-Ruiz de León C; García-Rodríguez J; Pérez-Castro N; Vigil-Díaz C; Pérez-Haro ML; Fernández-Gómez JM
Actas Urol Esp (Engl Ed); 2019; 43(1):32-38. PubMed ID: 30100141
[TBL] [Abstract][Full Text] [Related]
14. Positron emission tomography in uro-oncology.
Hain SF
Cancer Imaging; 2005 Jan; 5(1):1-7. PubMed ID: 16154810
[TBL] [Abstract][Full Text] [Related]
15. Serendipitous detection of testicular seminoma on F-18 FDG positron tomography.
Ali I; Johns W; Bottger B; Gupta SM
Clin Nucl Med; 2007 Mar; 32(3):201-2. PubMed ID: 17314595
[No Abstract] [Full Text] [Related]
16. Positron emission tomography for urological tumours.
Hain SF; Maisey MN
BJU Int; 2003 Jul; 92(2):159-64. PubMed ID: 12823366
[TBL] [Abstract][Full Text] [Related]
17. [2002 Standards, Options and Recommendations for the use of [18F]-FDG (PET-FDG) in cancerology].
Bourguet P;
Bull Cancer; 2003 Feb; 90 Spec No():S1-109. PubMed ID: 12744225
[No Abstract] [Full Text] [Related]
18. Positron-emission tomography imaging in urological oncology: Current aspects and developments.
Rauscher I; Eiber M; Weber WA; Gschwend JE; Horn T; Maurer T
Int J Urol; 2018 Nov; 25(11):912-921. PubMed ID: 30103285
[TBL] [Abstract][Full Text] [Related]
19. PET/Computed Tomography in Renal, Bladder, and Testicular Cancer.
Bouchelouche K; Choyke PL
PET Clin; 2015 Jul; 10(3):361-74. PubMed ID: 26099672
[TBL] [Abstract][Full Text] [Related]
20. [Clinical analysis of the indication for lymphangiography in urological tumor patients (author's transl)].
Rübben H; Lutzeyer W
Urologe A; 1981 Jan; 20(1):31-7. PubMed ID: 7013234
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
